BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 13, 2020
View Archived Issues
BeyondSpring submits patent application for BPI-002 as antiviral treatment
Read More
Virometix receives approval to initiate phase I study of V-306
Read More
Phase I results for vesatolimod in HIV controllers
Read More
First-in-human data for AAV8-coRPGR gene therapy
Read More
New mouse model of Charcot arthropathy
Read More
GARDP and Daiichi Sankyo partner for the discovery of new antibiotics
Read More
Medicago announces advances in the production of vaccine candidate for COVID-19
Read More
PLX cells to be developed for the potential treatment of complications caused by COVID-19
Read More
Positive results presented from phase Ib portion of PREVAIL study of PRV-3279
Read More
5-Hydroxymethylcytosine is a marker in classical Hodgkin's lymphoma
Read More
AbbVie receives EC approval of Venclyxto plus obinutuzumab for adults with CLL
Read More
Obschestvo S Ogranichennoi Otvetstvennostiyu "Z Therapeutics" divulges GC inhibitors
Read More
Roche patents Toll-like receptor antagonists
Read More
Mirati Therapeutics and Array BioPharma identify KRAS mutant inhibitors
Read More
Arcus Biosciences presents new CD73 inhibitors
Read More
Phase II data reported for RP-101 in moderate-to-severe DED
Read More
New mouse model with reduced editing in AMPA receptor GluA2(Q) site to study CNS disorders
Read More
Cytokinetics describes new cardiac myosin inhibitors
Read More
KIF15, MAD1L1 and DEPTOR expression are associated with susceptibility to IPF, large GWAS shows
Read More
First patient dosed in phase II study of HLX-10 plus chemotherapy in advanced cervical cancer
Read More
AbCellera and Eli Lilly establish collaboration to codevelop antibody products for COVID-19
Read More
Dual PMIX/PMX inhibitor WM-382 clears malaria parasites in vivo
Read More
CROI 2020: For beating HIV, how good is best?
Read More
Emergent BioSolutions begins development of hyperimmune-based candidates for COVID-19
Read More
Chinese trial studies utility of ASC-09F for COVID-19 pneumonia
Read More
ART-24 begins phase I trial for prevention of recurrence of C. difficile infection
Read More
FDA approves Opdivo plus Yervoy for the treatment of HCC previously treated with sorafenib
Read More
